The National Institutes of Health (NIH) has released the funding opportunity RFA-CA-24-013, titled “Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional).” Falling under the category of Cancer Detection and Diagnosis Research (CFDA Number: 93.394), this grant invites currently funded NCI U01 research projects to enhance their studies by integrating new technological advancements. With an award ceiling of $150,000, the initiative seeks to foster significant progress in cancer research by incorporating innovative tools and methods developed under the NCI Innovative Molecular Analysis Technologies (IMAT) program. The goal is to expand upon the original research questions, offering a unique opportunity for researchers to accelerate their studies and explore new dimensions in cancer research.
This Notice of Funding Opportunity (NOFO) emphasizes the importance of interdisciplinary collaboration and the integration of cutting-edge technology in cancer research. By inviting revision applications to incorporate novel NCI-supported technologies, the NIH aims to drive rapid advancements in the field, facilitating the adoption of these emerging tools within the appropriate research communities. This initiative not only promotes the development of innovative cancer research methods but also accelerates scientific discovery, potentially leading to breakthroughs in cancer detection, diagnosis, and treatment. The funding opportunity represents a strategic effort to enhance current cancer research projects, making them more efficient and effective in addressing the complex challenges of oncology. Through this initiative, the NIH demonstrates its commitment to fostering innovation and collaboration in cancer research, with the ultimate goal of improving patient outcomes and expanding our understanding of this critical field.
Opportunity ID: 351179
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-013 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 28, 2023 |
| Last Updated Date: | Nov 28, 2023 |
| Original Closing Date for Applications: | Oct 01, 2024 |
| Current Closing Date for Applications: | Oct 01, 2024 |
| Archive Date: | Nov 06, 2024 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $150,000 |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |